FORT MYERS — Neogenomics, a cancer-testing laboratory, reported a smaller net loss in the second quarter as revenues grew 23% compared with the same quarter in 2010.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition